Source disclosure: January 27, 2026
Genky DrugStores Co., Ltd. [9267.T]
TOKYO, Jan 27 (Pulse News Wire) – Genky Drugstores CO.,LTD. (9267.T) reported its fiscal 2026 second quarter earnings, showing revenue of ¥53.218 billion, slightly below initial forecasts due to lower-than-planned sales growth.
Despite challenges, operating profit reached ¥2.323 billion, marking a 144% increase year-over-year. Sales per transaction rose amid higher food prices, while customer traffic remained steady, up 0.7%. Cost management was stringent, with general and administrative expenses coming in at ¥8.342 billion, below plan thanks to efficient labor cost controls and reduced promotional spending.
The company maintained its focus on low-cost operations through initiatives such as self-checkout systems and streamlined store layouts, which helped offset some of the impact from rising input costs. For the full fiscal year ending June 2026, Genky revised its forecast, expecting revenue to grow by 4.3%, with operating profit projected to reach ¥11.050 billion, a slight improvement from previous estimates. The company plans to continue expanding its store network, aiming for 61 new openings despite ongoing economic headwinds.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing